Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-Month results from the IN.PACT deep randomized trial

Journal of the American College of Cardiology

Volumn 64, Issue 15, 2014, Pages 1568-1576

  Zeller, Thomas ^a   Baumgartner, Iris ^b   Scheinert, Dierk ^c   Brodmann, Marianne ^d   Bosiers, Marc ^e   Micari, Antonio ^f   Peeters, Patrick ^g   Vermassen, Frank ^h   Landini, Mario ⁱ   Snead, David B ⁱ   Kent, K Craig ^j   Rocha Singh, Krishna J ^k  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c Park Hospital Leipzig   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e Hospital Sint Blasius   (Belgium)

^f Research Ettore Sansavini Health Science Foundation   (Italy)

^g IMELDA HOSPITAL   (Belgium)

^h GHENT UNIVERSITY HOSPITAL   (Belgium)

ⁱ MEDTRONIC INC   (United States)

^j UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^k ST JOHN'S HOSPITAL   (United States)

more..

Author keywords

critical limb ischemia; drug eluting balloon; peripheral vascular disease

Indexed keywords

PACLITAXEL;

AGED; ANGIOGRAPHY; ARTICLE; BALLOON; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DRUG ELUTING BALLOON; FEMALE; HUMAN; INFRAPOPLITEAL ARTERIAL REVASCULZATION; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PATIENT SAFETY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; TREATMENT OUTCOME; WOUND CARE; WOUND HEALING; ARTERIAL OCCLUSIVE DISEASES; CLINICAL TRIAL; COMPLICATION; DRUG ELUTING STENT; FOLLOW UP; ISCHEMIA; LEG; POPLITEAL ARTERY; PROCEDURES; SINGLE BLIND PROCEDURE; VASCULAR SURGERY; VASCULARIZATION;

AGED; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIA; LEG; MALE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84908130786     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.06.1198     Document Type: Article

References (31)

1. E. Faglia, G. Clerici, and J. Clerissi Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients Eur J Vasc Endovasc Surg 32 2006 484 490
2. L. Graziani, A. Silvestro, and V. Bertone Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity Eur J Vasc Endovasc Surg 33 2007 453 460
3. E. Faglia, G. Clerici, and J. Clerissi When is a technically successful peripheral angioplasty effective in preventing above-the-ankle amputation in diabetic patients with critical limb ischaemia? Diabet Med 24 2007 823 829
4. R.C. Lo, J. Darling, and R.P. Bensley Outcomes following infrapopliteal angioplasty for critical limb ischemia J Vasc Surg 57 2013 1455 1463
5. F. Baumann, T. Willenberg, and D.D. Do Endovascular revascularization of below-the-knee arteries: prospective short-term angiographic and clinical follow-up J Vasc Interv Radiol 22 2011 1665 1673
6. R. Gandini, T. Volpi, and E. Pampana Applicability and clinical results of percutaneous transluminal angioplasty with a novel, long, conically shaped balloon dedicated for below-the knee interventions J Cardiovasc Surg (Torino) 50 2009 365 371
7. T. Kudo, F.A. Chandra, and S.S. Ahn The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience J Vasc Surg 41 2005 423 435
8. K. Ouriel Peripheral arterial disease Lancet 358 2001 1257 1264
9. M.S. Conte, P.J. Geraghty, and A.W. Bradbury Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia J Vasc Surg 50 2009 1462 1473
10. O. Iida, Y. Soga, and D. Kawasaki Angiographic restenosis and its clinical impact after infrapopliteal angioplasty Eur J Vasc Endovasc Surg 44 2012 425 431
11. A.W. Bradbury, D.J. Adam, J. Bell for the BASIL trial Participants Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received J Vasc Surg 51 2010 18S 31S
12. B.W. Nolan, R.R. De Martino, D.H. Stone for the Vascular Study Group of New England Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass J Vasc Surg 54 2011 730 735
13. A. Schmidt, M. Piorkowski, and M. Werner First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome J Am Coll Cardiol 58 2011 1105 1109
14. F. Liistro, I. Porto, and P. Angioli Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia Circulation 128 2013 615 621
15. Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia (INPACT-DEEP). July 16, 2009, updated February 3, 2014. Available at: http://clinicaltrials.gov/show/NCT00941733. Accessed August 4, 2014.
16. T. Zeller, I. Baumgartner, D. Scheinert for the IN.PACT DEEP Trial Investigators IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial Trials 15 2014 63
17. A. Schmidt, M. Ulrich, and B. Winkler Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease Catheter Cardiovasc Interv 76 2010 1047 1054
18. M. Romiti, M. Albers, and F.C. Brochado-Neto Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia J Vasc Surg 47 2008 975 981
19. A. Lejay, Y. Georg, and C. Bajcz Endovascular treatment of infra-popliteal arteries in patients with critical limb ischemia Acta Chir Belg 109 2009 684 693
20. D. Scheinert, K. Katsanos, T. Zeller for the ACHILLES Investigators A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial J Am Coll Cardiol 60 2012 2290 2295
21. A. Rastan, K. Brechtel, and H. Krankenberg Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial J Am Coll Cardiol 60 2012 587 591
22. D.J. Adam, J.D. Beard, and T. Cleveland Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial Lancet 366 2005 1925 1934
23. E. Blair Gold is not always good enough: the shortcomings of randomization when evaluating interventions in small heterogeneous samples J Clin Epidemiol 57 2004 1219 1222
24. A. Dechartres, I. Boutron, and L. Trinquart Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study Ann Intern Med 155 2011 39 51
25. R. Bellomo, S.J. Warrillow, and M.C. Reade Why we should be wary of single-center trials Crit Care Med 37 2009 3114 3119
26. J. Belch, W.R. Hiatt, I. Baumgartner for the TAMARIS Committees and Investigators Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia Lancet 377 2011 1929 1937
27. S. Nikol, I. Baumgartner, E. Van Belle for the TALISMAN 201 Investigators Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia Mol Ther 16 2008 972 978
28. M. Werk, T. Albrecht, and D.R. Meyer Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial Circ Cardiovasc Interv 5 2012 831 840
29. A. Micari, A. Cioppa, and G. Vadalà 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry J Am Coll Cardiol Intv 6 2013 282 289
30. G. Tepe, T. Zeller, and T. Albrecht Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
31. D. Scheinert, S. Duda, and T. Zeller The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty J Am Coll Cardiol Intv 7 2014 10 19